Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVanquis Banking Regulatory News (VANQ)

Share Price Information for Vanquis Banking (VANQ)

Share Price is delayed by 15 minutes
Get Live Data
107.60    0.40 (0.37%)
Bid:
107.60
Ask:
108.00
Spread: 0.40 (0.372%)
Market Cap: £269.36m
VANQ Live PriceLast checked at - London Stock Exchange

Intraday Vanquis Banking Share Chart

Block Listing Application

25 Oct 2023 07:00

RNS Number : 1378R
Vanquis Banking Group PLC
25 October 2023
 

 

Vanquis Banking Group plc

Block Listing Application

25 October 2023

 

 

Vanquis Banking Group plc (the "Company") is a leading specialist banking group with a focus on underserved markets.

 

Block Listing Application

 

Application has been made to the Financial Conduct Authority (FCA) and to the London Stock Exchange for 5,500,000 ordinary shares of 20 8/11 pence each in the capital of the Company (the "Block Listing Shares") to be admitted to the premium listing segment of the Official List of the FCA and to trading on the London Stock Exchange's main market for listed securities using a block listing "Block Listing Admission".

 

The Block Listing Shares will, upon issue, rank pari passu with the existing ordinary shares of the Company.

 

The Block Listing Shares will be issued by the Company from time to time under the terms of the following share plans: a) Vanquis Banking Group Long Term Incentive Scheme 2015, b) Vanquis Banking Group Deferred Bonus Plan 2022, and c) Vanquis Banking Group Savings Related Share Option Scheme 2022.

 

The Block Listing Admission is expected to become effective on 27 October 2023.

 

This notification is provided in accordance with paragraph 3.3.5R of the Listing Rules.

 

For further information please contact:

 

David Whincup

Deputy Company Secretary

Telephone: (0)1274 351 351

Email: david.whincup@vanquisbankinggroup.com

www.vanquisbankinggroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSFLFLLISLSFIV
Date   Source Headline
1st Feb 20247:05 amRNSDirectorate Change
1st Feb 20247:00 amRNSFull year trading update
31st Jan 20244:30 pmRNSTotal Voting Rights
23rd Jan 20245:11 pmRNSHolding(s) in Company
15th Jan 20243:00 pmRNSBlock listing Interim Review
2nd Jan 20247:00 amRNSTotal Voting Rights
18th Dec 20233:01 pmRNSHolding(s) in Company
30th Nov 20234:30 pmRNSTotal Voting Rights
9th Nov 20234:00 pmRNSPublication of Offering Circular
6th Nov 202311:48 amRNSDirector/PDMR Shareholding
1st Nov 20237:00 amRNSDirectorate Change
31st Oct 20234:30 pmRNSTotal Voting Rights
25th Oct 20237:00 amRNSBlock Listing Application
17th Oct 20237:00 amRNSThird quarter trading statement
27th Sep 20237:00 amRNSChief Financial Officer Appointment
18th Sep 20235:52 pmRNSDirectorate Change
15th Sep 202310:53 amRNSHolding(s) in Company
13th Sep 20234:02 pmRNSHolding(s) in Company
11th Sep 20231:06 pmRNSHolding(s) in Company
11th Sep 202311:30 amRNSDirector/PDMR Shareholding
11th Sep 202310:11 amRNSHolding(s) in Company
31st Aug 20234:30 pmRNSTotal Voting Rights
25th Aug 202312:35 pmRNSHolding(s) in Company
15th Aug 20231:04 pmRNSHolding(s) in Company
14th Aug 20233:44 pmRNSHolding(s) in Company
9th Aug 20234:10 pmRNSHolding(s) in Company
9th Aug 20233:00 pmRNSDirector/PDMR Shareholding
7th Aug 20233:12 pmRNSIssue of Equity
7th Aug 20238:59 amRNSCFO Succession
1st Aug 20232:15 pmRNSDirector/PDMR Shareholding
31st Jul 20234:41 pmRNSTotal Voting Rights
31st Jul 20237:00 amRNSSnoop Acquisition
28th Jul 20237:00 amRNSInterim Results for six months ended 30 June 2023
26th Jul 20231:00 pmRNSHolding(s) in Company
14th Jul 20233:11 pmRNSBlock listing Interim Review
3rd Jul 20231:13 pmRNSDirector/PDMR Shareholding
30th Jun 20234:30 pmRNSTotal Voting Rights
30th Jun 20237:00 amRNSChair Appointment
27th Jun 20232:37 pmRNSHolding(s) in Company
27th Jun 20231:51 pmRNSHolding(s) in Company
1st Jun 20233:52 pmRNSHolding(s) in Company
31st May 20234:30 pmRNSTotal Voting Rights and Capital
25th May 20231:30 pmRNSResult of Annual General Meeting
25th May 20237:00 amRNSFirst quarter trading statement
19th May 20237:00 amRNSChairman succession
28th Apr 20234:30 pmRNSTotal Voting Rights
19th Apr 20232:00 pmRNSDirector Declaration
19th Apr 20237:00 amRNSNon-Executive Director Appointment
13th Apr 20231:00 pmRNSDirector/PDMR Shareholding
12th Apr 202310:41 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.